Onconetix, Inc. — Director's Dealing 2022

Aug 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-08-18

Reporting Person: Henderson Erin (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	Common Stock	F	24752	$0.01	Acquired	24752	Direct
2022-08-19	Common Stock	F	4834	$0.01	Acquired	29586	Direct
2022-08-19	Common Stock	S	4834	$3.97	Disposed	24752	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-18	Stock Option	$0.01	F	24810	Disposed	2030-04-02	Common Stock (24810)	Direct
2022-08-19	Stock Option	$0.01	F	4834	Disposed	2030-04-02	Common Stock (4834)	Direct

Footnotes

F1: The Common Stock reported herein were sold by the reporting person at a high price of $4.00, a low price of $3.96 and an average price of $3.97 per share of Common Stock. Upon request, the reporting person will provide details of each sale.